OTCMKTS:MDCN

Medican Enterprises Competitors

$0.0008
0.00 (-11.11 %)
(As of 04/16/2021 08:09 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.00
Volume451.17 million shs
Average Volume720.23 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medican Enterprises (OTCMKTS:MDCN) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying MDCN stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to Medican Enterprises, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Innovative Industrial Properties (NYSE:IIPR) and Medican Enterprises (OTCMKTS:MDCN) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and target prices for Innovative Industrial Properties and Medican Enterprises, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innovative Industrial Properties02502.71
Medican Enterprises0000N/A

Innovative Industrial Properties currently has a consensus target price of $192.4286, suggesting a potential upside of 4.05%. Given Innovative Industrial Properties' higher probable upside, analysts clearly believe Innovative Industrial Properties is more favorable than Medican Enterprises.

Profitability

This table compares Innovative Industrial Properties and Medican Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innovative Industrial Properties55.71%6.05%4.82%
Medican EnterprisesN/AN/AN/A

Valuation & Earnings

This table compares Innovative Industrial Properties and Medican Enterprises' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Industrial Properties$44.67 million99.06$23.48 million$3.2756.56
Medican EnterprisesN/AN/AN/AN/AN/A

Innovative Industrial Properties has higher revenue and earnings than Medican Enterprises.

Summary

Innovative Industrial Properties beats Medican Enterprises on 8 of the 8 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and Medican Enterprises (OTCMKTS:MDCN) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Valuation & Earnings

This table compares GrowGeneration and Medican Enterprises' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GrowGeneration$79 million34.85$1.88 million$0.10471.00
Medican EnterprisesN/AN/AN/AN/AN/A

GrowGeneration has higher revenue and earnings than Medican Enterprises.

Analyst Ratings

This is a summary of current ratings and target prices for GrowGeneration and Medican Enterprises, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
GrowGeneration03502.63
Medican Enterprises0000N/A

GrowGeneration currently has a consensus target price of $49.5714, suggesting a potential upside of 5.25%. Given GrowGeneration's higher probable upside, analysts clearly believe GrowGeneration is more favorable than Medican Enterprises.

Profitability

This table compares GrowGeneration and Medican Enterprises' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrowGeneration2.14%4.68%3.53%
Medican EnterprisesN/AN/AN/A

Institutional & Insider Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

GrowGeneration beats Medican Enterprises on 8 of the 8 factors compared between the two stocks.

Medican Enterprises (OTCMKTS:MDCN) and 22nd Century Group (NYSEAMERICAN:XXII) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and 22nd Century Group's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medican EnterprisesN/AN/AN/AN/AN/A
22nd Century GroupN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and 22nd Century Group, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medican Enterprises0000N/A
22nd Century Group00103.00

Profitability

This table compares Medican Enterprises and 22nd Century Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medican EnterprisesN/AN/AN/A
22nd Century GroupN/AN/AN/A

Summary

22nd Century Group beats Medican Enterprises on 1 of the 1 factors compared between the two stocks.

Medican Enterprises (OTCMKTS:MDCN) and KushCo (OTCMKTS:KSHB) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and KushCo's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medican EnterprisesN/AN/AN/AN/AN/A
KushCo$113.84 million1.65$-77,660,000.00($0.68)-1.74

Medican Enterprises has higher earnings, but lower revenue than KushCo.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and KushCo, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medican Enterprises0000N/A
KushCo01302.75

KushCo has a consensus target price of $1.8750, suggesting a potential upside of 58.90%. Given KushCo's higher probable upside, analysts plainly believe KushCo is more favorable than Medican Enterprises.

Profitability

This table compares Medican Enterprises and KushCo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medican EnterprisesN/AN/AN/A
KushCo-65.89%-47.95%-31.39%

Insider and Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

KushCo beats Medican Enterprises on 5 of the 8 factors compared between the two stocks.

Medican Enterprises (OTCMKTS:MDCN) and NSAV (OTCMKTS:NSAV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and NSAV's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medican EnterprisesN/AN/AN/AN/AN/A
NSAVN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and NSAV, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medican Enterprises0000N/A
NSAV0000N/A

Profitability

This table compares Medican Enterprises and NSAV's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medican EnterprisesN/AN/AN/A
NSAVN/AN/AN/A

Medican Enterprises (OTCMKTS:MDCN) and Terra Tech (OTCMKTS:TRTC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Valuation and Earnings

This table compares Medican Enterprises and Terra Tech's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medican EnterprisesN/AN/AN/AN/AN/A
Terra Tech$28.05 million2.15$-46,930,000.00N/AN/A

Medican Enterprises has higher earnings, but lower revenue than Terra Tech.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Medican Enterprises and Terra Tech, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medican Enterprises0000N/A
Terra Tech0000N/A

Profitability

This table compares Medican Enterprises and Terra Tech's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medican EnterprisesN/AN/AN/A
Terra Tech-261.88%-110.38%-62.41%

Insider and Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


Medican Enterprises Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$184.94-0.8%$4.42 billion$44.67 million59.85Analyst Revision
GrowGeneration logo
GRWG
GrowGeneration
1.5$47.10-0.6%$2.75 billion$79 million942.19Insider Selling
22nd Century Group logo
XXII
22nd Century Group
0.9$3.21-9.3%$489.20 millionN/A0.00Analyst Downgrade
Gap Down
KushCo logo
KSHB
KushCo
1.3$1.18-0.0%$187.47 million$113.84 million-1.97Gap Up
NSAV logo
NSAV
NSAV
0.3$0.02-1.1%$104.60 millionN/A0.00Gap Up
Terra Tech logo
TRTC
Terra Tech
0.7$0.26-3.7%$60.19 million$28.05 million0.00Decrease in Short Interest
Gap Up
General Cannabis logo
CANN
General Cannabis
0.6$0.68-4.4%$42.26 million$3.67 million0.00Gap Up
PVSP
Pervasip
0.4$0.01-0.0%$39.26 millionN/A0.00Increase in Short Interest
News Coverage
Gap Down
Grow Capital logo
GRWC
Grow Capital
0.6$1.09-8.3%$27.07 million$2.37 million0.00Gap Up
NMUS
Nemus Bioscience
0.6$0.65-10.5%$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16-6.5%$14.08 million$2.53 million0.00Gap Up
MassRoots logo
MSRT
MassRoots
0.6$0.02-1.8%$10.91 million$20,000.000.00
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.13-1.5%$10.19 millionN/A0.00
FutureWorld logo
FWDG
FutureWorld
0.5$0.00-0.0%$4.56 millionN/A0.00Gap Up
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.17-5.9%$3.86 million$4.33 million-4.23Gap Down
NGBL
Notis Global
0.5$0.00-0.0%$3.00 millionN/A0.00
DigiPath logo
DIGP
DigiPath
0.5$0.04-6.1%$2.89 million$2.55 million-1.41Gap Down
CrowdGather logo
CRWG
CrowdGather
0.7$0.01-23.0%$1.60 million$160,000.000.00Increase in Short Interest
Gap Down
United Cannabis logo
CNAB
United Cannabis
0.4$0.02-190.9%$1.23 millionN/A0.00High Trading Volume
Gap Up
OPMZ
1PM Industries
0.4$0.00-0.0%$0.00N/A0.00Gap Down
AQSP
Acquired Sales
0.4$7.90-1.3%$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.19-0.1%$0.00N/A0.00Gap Down
AmeriCann logo
ACAN
AmeriCann
0.4$1.30-0.8%$0.00N/A0.00Gap Up
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18-6.8%$0.00N/A0.00Gap Down
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.72-1.4%$0.00N/A0.00
FRLF
Freedom Leaf
0.5$0.07-86.3%$0.00N/A0.00Gap Down
FUTL
FutureLand
0.4$0.00-0.0%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-7.7%$0.00N/A0.00Increase in Short Interest
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02-7.6%$0.00N/A0.00News Coverage
Gap Up
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.88-2.0%$0.00N/A0.00Gap Down
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Increase in Short Interest
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.04-8.5%$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$1.90-13.7%$0.00N/A0.00
Northsight Capital logo
NCAP
Northsight Capital
0.5$0.00-60.0%$0.00N/A0.00Gap Down
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01-2.1%$0.00N/A0.00Gap Down
Surna logo
SRNA
Surna
0.6$0.06-3.1%$0.00N/A0.00Gap Up
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09-3.2%$0.00N/A0.00Gap Up
BUDZ
WEED
0.6$0.52-0.0%$0.00N/A0.00Gap Down
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.59-2.6%$0.00N/A0.00Gap Down
ZZLL
ZZLL Information Technology
0.4$0.32-57.2%$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.